Just diagnosed with CANOMAD syndrome?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees CANOMAD syndrome, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive CANOMAD syndrome hub →Overview
CANOMAD syndrome is a rare condition. Also known as CANDA syndrome, Chronic ataxic neuropathy-ophthalmoplegia-IgM paraprotein-cold agglutinins-disialosyl antibodies syndrome, Chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Tomeko brings together the specialists, research, clinical trials, treatments and community for CANOMAD syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:71279 · ICD-10 G61.8 · GARD 0009778
Find care for CANOMAD syndrome
Authoritative references for CANOMAD syndrome
Research & market landscape for CANOMAD syndrome
Following CANOMAD syndrome for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for CANOMAD syndrome — the real-world landscape behind the condition, in one place.
- Latest CANOMAD syndrome research on PubMed ↗
- Recruiting CANOMAD syndrome trials on ClinicalTrials.gov ↗
- Explore the CANOMAD syndrome research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for CANOMAD syndrome and every rare condition. See how Tomeko works with industry →
Common questions
What is CANOMAD syndrome?
CANOMAD syndrome is a rare condition. Also known as CANDA syndrome, Chronic ataxic neuropathy-ophthalmoplegia-IgM paraprotein-cold agglutinins-disialosyl antibodies syndrome, Chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for CANOMAD syndrome together in one place.
What are the symptoms of CANOMAD syndrome?
Symptoms of CANOMAD syndrome vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats CANOMAD syndrome.
How is CANOMAD syndrome treated?
Treatment for CANOMAD syndrome depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see CANOMAD syndrome, and review current options with them.
What causes CANOMAD syndrome — is it genetic?
The cause and inheritance of CANOMAD syndrome are described in the authoritative references linked on this page. A genetics or specialist clinician who treats CANOMAD syndrome can explain what it means for you and your family.
I was just diagnosed with CANOMAD syndrome — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees CANOMAD syndrome, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for CANOMAD syndrome?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat CANOMAD syndrome, filtered to your area.
Are there clinical trials for CANOMAD syndrome?
Tomeko shows live, recruiting studies for CANOMAD syndrome from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion